2022. Evaluation of the pharmacotherapeutic follow-up effectiveness in patients with dyslipidemia in the secondary health care in the Brazilian Unified Health System (SUS). Brazilian Journal of Pharmaceutical Sciences. 58, (Dec. 2022). DOI:https://doi.org/10.1590/s2175-97902022e20400.